A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors.Published in:2014By:Mateo, J;Berlin, J;de Bono, J S;Cohen, R B;Keedy, V;Mugundu, G;Zhang, Lianglin;Abbattista, A;Davis, C;Gallo Stampino, C;Borghaei, HPublication type:journal article
A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors.Published in:Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1039, doi. 10.1007/s00280-014-2576-8By:Mateo, J.;Berlin, J.;Bono, J.;Cohen, R.;Keedy, V.;Mugundu, G.;Zhang, Lianglin;Abbattista, A.;Davis, C.;Gallo Stampino, C.;Borghaei, H.Publication type:Article